prednisolone has been researched along with Mucopolysaccharidosis III in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mucopolysaccharidosis IIIB is a paediatric lysosomal storage disease caused by deficiency of the enzyme α-N-acetylglucosaminidase (NAGLU), involved in the degradation of the glycosaminoglycan heparan sulphate." | 1.48 | Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. ( Bigger, BW; D'Souza, Z; Dickson, PI; Ellison, SM; Fil, D; Gleitz, HFE; Holley, RJ; Kan, SH; Langford-Smith, AWW; Liao, A; McDermott, J; O'Leary, C; Parker, H; Rowlston, S; Senthivel, N; Wilkinson, FL, 2018) |
| "The mechanism of neuropathology in MPS IIIB is unclear." | 1.35 | Innate and adaptive immune activation in the brain of MPS IIIB mouse model. ( Auer, H; Best, V; Charrier, A; DiRosario, J; Divers, E; Etter, J; Fu, H; Jukkola, P; McCarty, DM; Newsom, DL; Wang, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holley, RJ | 1 |
| Ellison, SM | 1 |
| Fil, D | 1 |
| O'Leary, C | 1 |
| McDermott, J | 1 |
| Senthivel, N | 1 |
| Langford-Smith, AWW | 1 |
| Wilkinson, FL | 1 |
| D'Souza, Z | 1 |
| Parker, H | 1 |
| Liao, A | 1 |
| Rowlston, S | 1 |
| Gleitz, HFE | 1 |
| Kan, SH | 1 |
| Dickson, PI | 1 |
| Bigger, BW | 1 |
| DiRosario, J | 1 |
| Divers, E | 1 |
| Wang, C | 1 |
| Etter, J | 1 |
| Charrier, A | 1 |
| Jukkola, P | 1 |
| Auer, H | 1 |
| Best, V | 1 |
| Newsom, DL | 1 |
| McCarty, DM | 1 |
| Fu, H | 1 |
2 other studies available for prednisolone and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
Topics: Animals; Brain; Cytokines; Disease Models, Animal; Encephalitis; Female; Genetic Therapy; Gliosis; G | 2018 |
Innate and adaptive immune activation in the brain of MPS IIIB mouse model.
Topics: Animals; Astrocytes; Autoantibodies; Brain; Demyelinating Diseases; Disease Models, Animal; Disease | 2009 |